Biotech Values

[BTH]

I'm sure some academics are testing Soliris in DDD.

See here: http://clinicaltrials.gov/ct2/show/NCT01221181

As I am sure you now, Soliris targets C5, 1135 is supposed to target both C3 and C5. I have no idea if that will make a difference or not. No clue at all. They seem to think it may.

They had two patients ready to go, and they progressed too quickly prior to enrollment and were dropped prior to dosing. It is only an N=5 study. Yes, it's pathetically slow.... ridiculous. I'm not so sure they know what they are doing with this ultra-orphan stuff.